We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
AAB
451
ABN AMRO Bank
Netherlands
$7.98M +$3.46M +33,418 +69%
FAT
452
First American Trust
California
$7.9M +$24.5K +237 +0.3%
M&T Bank
453
M&T Bank
New York
$7.9M -$2.85M -27,565 -25%
CA
454
Cornerstone Advisors
North Carolina
$7.84M -$704K -6,800 -8%
AC
455
Armistice Capital
New York
$7.83M +$541K +5,223 +7%
NEI
456
Northwest & Ethical Investments
Ontario, Canada
$7.81M +$785K +7,581 +10%
CDDEC
457
Caisse Des Depots Et Consignations
France
$7.75M
CI
458
Cavalier Investments
Georgia
$7.71M +$2.6M +25,100 +50%
LSERS
459
Louisiana State Employees Retirement System
Louisiana
$7.6M -$31.1K -300 -0.4%
VA
460
Vident Advisory
Georgia
$7.59M +$2.31M +22,336 +40%
QCM
461
Qsemble Capital Management
New York
$7.58M +$5.93M +57,242 +280%
AI
462
Atria Investments
North Carolina
$7.56M +$3.71M +35,788 +86%
PF
463
Phoenix Financial
Israel
$7.45M -$3.83M -36,970 -33%
PM
464
Prosight Management
Texas
$7.43M +$7.88M +76,100 New
ACA
465
Aptus Capital Advisors
Alabama
$7.41M +$6.56M +63,382 +508%
P
466
&Partners
Tennessee
$7.37M +$1.8M +17,387 +30%
BLC
467
Brown, Lisle/Cummings
Rhode Island
$7.36M -$23.3K -225 -0.3%
Cambridge Investment Research Advisors
468
Cambridge Investment Research Advisors
Iowa
$7.32M +$2.18M +21,091 +39%
GIBU
469
Gulf International Bank (UK)
United Kingdom
$7.27M -$122K -1,176 -2%
BHCM
470
Brevan Howard Capital Management
Jersey
$7.21M -$420K -4,055 -5%
MSRPS
471
Maryland State Retirement & Pension System
Maryland
$7.19M +$194K +1,876 +3%
UB
472
UMB Bank
Missouri
$7.17M -$183K -1,766 -2%
NG
473
NWK Group
California
$7.15M -$23.6K -228 -0.3%
CG
474
Caprock Group
Idaho
$7.12M +$6.99M +67,449 New
FGP
475
Freestone Grove Partners
California
$7.07M +$7.5M +72,399 New

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.